Stereotactic Surgery Devices Market Size

Stereotactic Surgery Devices Market size was over USD 28.77 billion in 2024 and is poised to exceed USD 46.72 billion by 2037, witnessing over 3.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of stereotactic surgery devices is evaluated at USD 29.64 billion.

The reason behind the growth is due to the rising cases of cancer across the globe. Stereotactic radiosurgery, such as Gamma Knife, is a three-dimensional surgical technique and a very precise form of therapeutic radiation that is often used to treat noncancerous (benign), cancerous (malignant) brain tumors, and also to treat small, early-stage lung cancer and pancreatic cancer, or cancers that have spread to the lung, liver, or adrenal gland.

For instance, Cancer is one of the world's top causes of death, accounting for more than 9 million deaths in 2020, and it is anticipated that by 2040, there will be more than 27 million new cancer cases worldwide.

The growing technological advancements are believed to fuel the market growth. Stereotactic radiation is constantly being improved, owing to technological advances that aid in boosting treatment precision.